AAPGV: Nilai Buku Bisnis Ascentage Pharma Group International

Logo perusahaan publik Ascentage Pharma (AAPGV)

The price history of Ascentage Pharma Group (AAPGV) reflects the dynamics of an asset whose business relies on strict temperature monitoring during the transport of advanced medications. The current indicator is 0.05. Ascentage Pharma Group is implementing robotics to accelerate the selection of molecules that block tumor proteins. High authority among physicians and global medical partnerships strengthen shareholder confidence in the success of the therapies under development.

AAPGV Kapitalisasi Buku Ascentage Pharma Group (25.01.2025 - 28.10.2026)
Barang unggulan Ascentage

This indicator reflects the real value of the business through the difference between net assets and debt obligations, allowing the investor to assess internal financial stability and capital protection against bankruptcy. For Ascentage Pharma Group (AAPGV), such a foundation is critical when scaling the pipeline and entering the US market with olverematinib, which the book value dynamics clearly confirm.

Pesaing wigati

ONC - Nilai Aset Bersih|Kapitalisasi Buku HALO (Halozyme Therapeutics)|Nilai Buku Bisnis revmed.com|Aset Bersih Perusahaan Ascentage Pharma|Nilai Buku Perusahaan CG Oncology Inc|Kapitalisasi Buku URGN (UroGen)|Aset Bersih Perusahaan Bicara Corp (BCAX)|Kapitalisasi Buku PSNL (Personalis, Inc.)|erasca.com - Kapitalisasi Buku|Delcath Systems (DCTH) - Nilai Buku Perusahaan|YMAB - Kapitalisasi Akuntansi|AURA (Aura Bio) - Kapitalisasi Buku|Candel Therapeutics, Inc. (CADL) - Aset Bersih Perusahaan|Kapitalisasi Buku ARAY (Accuray Incorporated)|Ekuitas Perusahaan SLS|Actuate Therapeutics (ACTU) - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan Citius Oncology Inc. CTOR|Aset Bersih Perusahaan TuHURA Biosciences|Nilai Akuntansi Perusahaan Protara Tx TARA|FATE: Kapitalisasi Buku|Aadi Bioscience Inc (WHWK) - Aset Bersih Perusahaan|TCRX: Aset Bersih Perusahaan|CSBR (Champions Oncology, Inc.) - Kapitalisasi Buku|XBIT - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan CEL-SCI Corp|OS Therapies Incorporated - Kapitalisasi Buku|Ekuitas Perusahaan Radiopharm Theranostics Ltd (RADX)|Kapitalisasi Buku ARTV (Artiva Biotherapeutics)|Adlai Nortye Ltd - Kapitalisasi Buku|Nilai Buku Perusahaan VERU (Veru Pharma)|TPST - Pambiji Buku Bisnis|XLO (xiliotx.com) - Kapitalisasi Buku|Renovaro (RENB) - Aset Bersih Perusahaan|Kapitalisasi Buku MURA (Mural Oncology PLC)|Ekuitas Perusahaan KAPA|Nilai Buku Perusahaan OnKure Therapeutics Inc OKUR|Kapitalisasi Akuntansi w2.cytomed.sg GDTC|Aset Bersih Perusahaan Curis (CRIS)|Total Aset Bersih Apollomics Inc. APLM|Tharimmune - Kapitalisasi Buku|ADVB - Kapitalisasi Buku|Kapitalisasi Buku GNPX (Genprex, Inc)|Calidi Biotherapeutics, Inc. (CLDI) - Nilai Buku Bisnis|Kapitalisasi Buku SBFM (Sunshine Biopharma)|Ekuitas Perusahaan Xenetic Bio (XBIO)|Salarius Pharmaceuticals, Inc. (SLRX) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan PPBT (Purple Biotech Ltd)|American Oncology Network, Inc. (AONC) - Nilai Buku Perusahaan|Nilai Aset Bersih BeiGene Ltd BGNE|Kapitalisasi Buku Checkpoint Therapeutics (CKPT)|ELEV - Nilai Akuntansi Perusahaan|ICAD: Kapitalisasi Buku|IKNA (Ikena Oncology) - Kapitalisasi Buku|NTBL - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan VIRX|Nilai Buku Perusahaan MOR (MorphoSys AG)|Aset Bersih Perusahaan nayabiosciences.com (NAYA)